Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach

BACKGROUND AND AIM: Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world pandemic. There is a race to develop suitable drugs and vaccines for the disease. The anti-HIV protease drugs are currently repurposed for the poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Rangsinth, Panthakarn, Sillapachaiyaporn, Chanin, Nilkhet, Sunita, Tencomnao, Tewin, Ung, Alison T., Chuchawankul, Siriporn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836338/
https://www.ncbi.nlm.nih.gov/pubmed/33520685
http://dx.doi.org/10.1016/j.jtcme.2020.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836338/
https://www.ncbi.nlm.nih.gov/pubmed/33520685
http://dx.doi.org/10.1016/j.jtcme.2020.12.002

Ejemplares similares